Canopy Growth Corporation (NYSE: CGC) reported fourth-quarter 2021 earnings results today.
Net revenues increased 38% year-over-year to CAD $148 million.
Net loss attributable to Canopy Growth Corporation was CAD $699 million, or CAD $1.85 per share, versus a net loss of CAD $1.3 billion, or CAD $3.72 per share, last year.
The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for
The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated